Skip to content

Clinical trials

Angioedemas, Hereditary trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angioedemas, Hereditary Country / region: Australia Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20121
20141
20161
20182
20212
20226
20231
20242
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting5
Recruiting4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring5
Pharvaris Netherlands B.V.4
ADARx Pharmaceuticals, Inc.3
Intellia Therapeutics3
KalVista Pharmaceuticals, Ltd.3
Shire3
BioCryst Pharmaceuticals2
Astria Therapeutics, Inc.1
BioMarin Pharmaceutical1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angioedemas, Hereditary26
Hereditary Angioedema Types I and II3
Angioedema2
Hereditary Angioedema Type III2

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.